Marcello Arca

Pubblicazioni

Titolo Pubblicato in Anno
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional-Based Italian Database JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2024
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study THE LANCET 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia JAMA CARDIOLOGY 2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries EUROPEAN JOURNAL OF INTERNAL MEDICINE 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice? CURRENT ATHEROSCLEROSIS REPORTS 2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. LIVER INTERNATIONAL 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study LA RADIOLOGIA MEDICA 2023
[Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion] GIORNALE ITALIANO DI CARDIOLOGIA 2023
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2023
Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA) NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES 2023
Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study EUROPEAN JOURNAL OF INTERNAL MEDICINE 2023
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial JOURNAL OF CLINICAL LIPIDOLOGY 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study THE LANCET REGIONAL HEALTH. EUROPE 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group NUTRIENTS 2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis CIRCULATION 2023
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] GIORNALE ITALIANO DI CARDIOLOGIA 2023
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study ATHEROSCLEROSIS 2023

Progetti di Ricerca

Laboratori di ricerca

Laboratorio di Genomica in Medicina di Precisione

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma